Legend Biotech (LEGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AEP’s long-term (three to five years) earnings growth rate is 6.43%. The Zacks Consensus Estimate for earnings is pinned at ...

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor. But what's the best way to find the right combination ...

DuPont de Nemours came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.95 per ...

KLA (KLAC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most ...

Zacks.com users have recently been watching Advanced Micro (AMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

For those looking to find strong Utilities stocks, it is prudent to search for companies in the group that are outperforming their peers. RWE AG (RWEOY) is a stock that can certainly grab the ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

NVIDIA CorporationNVDA stock gained nearly 2.5% on Thursday, buoyed by a renewed wave of optimism from two of its largest ...

Intuit (INTU) has demonstrated resilience in the latest trading session, closing at $627.86 with a modest 0.76% increase, outperforming the broader market indices. This article delves into Intuit's ...